RETINALGENIX TECHNOLOGIES INC. Research and Development in Process
RETINALGENIX TECHNOLOGIES INC. (RTGN) reported Research and Development in Process of $2.03 million for the 12-month period ending 2022-12-31, per its 10-K/A filed 2023-06-15.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentInProcess · last filed 2023-06-15
- RETINALGENIX TECHNOLOGIES INC. research and development in process for the quarter ending 2022-12-31 was $0.00.
- RETINALGENIX TECHNOLOGIES INC. research and development in process for the quarter ending 2022-09-30 was $2.03M.
- RETINALGENIX TECHNOLOGIES INC. research and development in process for fiscal 2022 was $2.03M.
| Period end | Research and Development in Process 3 month | Research and Development in Process 6 month | Research and Development in Process 9 month | Research and Development in Process 12 month |
|---|---|---|---|---|
| 2022-12-31 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-06-15 | $2.03M derived: sum of 2 quarters · filed 2023-06-15 | $2.03M 10-K/A · filed 2023-06-15 | |
| 2022-09-30 | $2.03M 10-Q · filed 2022-11-17 | $2.03M 10-Q · filed 2022-11-17 |